+351 21 432 95 00




Actualidades

Jaba Recordati lança gama para o tratamento de aftas

Aloclair® Plus - Gama de tratamento para as aftas

A Jaba Recordati acaba de lançar uma gama de tratamento para as aftas - a Aloclair® Plus.

THE EUROPEAN COMMISSION APPROVES REAGILA® (CARIPRAZINE) FOR THE TREATMENT OF SCHIZOPHRENIA

Recordati News Release

Recordati announces that Gedeon Richter Plc. was granted marketing authorization from the European Commission for Reagila® (cariprazine), a novel antipsychotic for the treatment of schizophrenia in adult patientsvalid for all European Union Member States. In August 2016 Richter and Recordati signed an exclusive license agreement to commercialize cariprazine in Western Europe, Algeria, Tunisia and Turkey.

Jaba Recordati, S.A. / Lagoas Park / Edifício 5, Torre C, Piso 3 / 2740-245 Porto Salvo
T. +351 214 329 500 / F. +351 219 151 930 / E. geral@jaba-recordati.pt
2016 © Jaba Recordati | POWERED BY bluesoft | 100% Get On
TransAct® Lat | facebook